Literature DB >> 15686965

Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat.

Kunlin Jin1, Yunjuan Sun, Lin Xie, Xiao Ou Mao, Joycelyn Childs, Alyson Peel, Anna Logvinova, Surita Banwait, David A Greenberg.   

Abstract

Cell replacement therapy may have the potential to promote brain repair and recovery after stroke. To compare how focal cerebral ischemia affects the entry, migration, and phenotypic features of neural precursor cells transplanted by different routes, we administered neuronal precursors from embryonic cerebral cortex of green fluorescent protein (GFP)-expressing transgenic mice to rats that had undergone middle cerebral artery occlusion (MCAO) by the intrastriatal, intraventricular, and intravenous routes. MCAO increased the entry of GFP-immunoreactive cells, most of which expressed neuroepithelial (nestin) or neuronal (doublecortin) markers, from the ventricles and bloodstream into the brain, and enhanced their migration when delivered by any of these routes. Transplanted neural precursors migrated into the ischemic striatum and cerebral cortex. Thus, transplantation of neural precursors by a variety of routes can deliver cells with the potential to replace injured neurons to ischemic brain regions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15686965     DOI: 10.1016/j.nbd.2004.10.010

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  64 in total

1.  Quantitative analysis of neural stem cell migration and tracer clearance in the rat brain by MRI.

Authors:  Jennifer A Flexman; Donna J Cross; Linh N Tran; Takahiro Sasaki; Yongmin Kim; Satoshi Minoshima
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

2.  Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia.

Authors:  Arjun V Pendharkar; Josh Y Chua; Robert H Andres; Nancy Wang; Xavier Gaeta; Hui Wang; Abhijit De; Raymond Choi; Shawn Chen; Brian K Rutt; Sanjiv S Gambhir; Raphael Guzman
Journal:  Stroke       Date:  2010-07-08       Impact factor: 7.914

3.  The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain.

Authors:  Robert H Andres; Raymond Choi; Arjun V Pendharkar; Xavier Gaeta; Nancy Wang; Jaya K Nathan; Joshua Y Chua; Star W Lee; Theo D Palmer; Gary K Steinberg; Raphael Guzman
Journal:  Stroke       Date:  2011-08-11       Impact factor: 7.914

Review 4.  Update on therapeutic mechanism for bone marrow stromal cells in ischemic stroke.

Authors:  Huan Wan; Fangqin Li; Lei Zhu; Jing Wang; Zizhen Yang; Yujun Pan
Journal:  J Mol Neurosci       Date:  2013-09-19       Impact factor: 3.444

Review 5.  Current status of cell therapies in stroke.

Authors:  Oh Young Bang
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

6.  Intravascular stem cell transplantation for stroke.

Authors:  Angela M Auriat; Sahar Rosenblum; Tenille N Smith; Raphael Guzman
Journal:  Transl Stroke Res       Date:  2011-08-04       Impact factor: 6.829

Review 7.  Neural stem cell therapies and hypoxic-ischemic brain injury.

Authors:  Lei Huang; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2018-05-21       Impact factor: 11.685

8.  Electrophysiological properties of mouse cortical neuron progenitors differentiated in vitro and in vivo.

Authors:  Weizhen Wang; Kunlin Jin; Xiao-Ou Mao; Natasha Close; David A Greenberg; Zhi-Gang Xiong
Journal:  Int J Clin Exp Med       Date:  2008-03-06

Review 9.  Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

Authors:  Nathan P Staff; David T Jones; Wolfgang Singer
Journal:  Mayo Clin Proc       Date:  2019-05       Impact factor: 7.616

10.  Tetramethylpyrazine Promotes Migration of Neural Precursor Cells via Activating the Phosphatidylinositol 3-Kinase Pathway.

Authors:  Xiangying Kong; Micun Zhong; Xiaohui Su; Qingxia Qin; Hongchang Su; Hongye Wan; Cuiling Liu; Jiajia Wu; Hongcai Shang; Yanjun Zhang; Na Lin
Journal:  Mol Neurobiol       Date:  2015-11-28       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.